Detalhe da pesquisa
1.
Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis.
J Endocrinol Invest
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503992
2.
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management.
J Endocrinol Invest
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38809458
3.
Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly.
J Endocrinol Invest
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38787507
4.
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy.
J Endocrinol Invest
; 47(6): 1457-1465, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214852
5.
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency.
J Endocrinol Invest
; 46(3): 587-597, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251244
6.
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone.
J Endocrinol Invest
; 46(3): 535-543, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161398
7.
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency?
J Endocrinol Invest
; 46(10): 2175-2183, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062055
8.
Neuroendocrine response to diclofenac in healthy subjects: a pilot study.
J Endocrinol Invest
; 46(12): 2617-2627, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243865
9.
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test.
J Endocrinol Invest
; 45(5): 981-987, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098493
10.
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy.
J Endocrinol Invest
; 45(10): 1955-1965, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748978
11.
Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY.
J Endocrinol Invest
; 45(8): 1535-1545, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35359232
12.
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment.
Pituitary
; 24(2): 242-251, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164134
13.
Pituitary surgery during Covid-19: a first hand experience and evaluation.
J Endocrinol Invest
; 44(3): 635-636, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651894
14.
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study.
J Endocrinol Invest
; 44(8): 1699-1706, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33314003
15.
First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence.
J Endocrinol Invest
; 44(11): 2427-2433, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837920
16.
The prevalence of silent acromegaly in prolactinomas is very low.
J Endocrinol Invest
; 44(3): 531-539, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594452
17.
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study.
J Endocrinol Invest
; 43(2): 197-207, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440920
18.
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients.
J Endocrinol Invest
; 43(11): 1661-1667, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333332
19.
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.
Pituitary
; 22(5): 552-560, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31032537
20.
Correction to: Pegvisomant in acromegaly: an update.
J Endocrinol Invest
; 41(2): 267, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285678